Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: An attempt for modelling some symptoms of psychosis in man

Journal of Psychopharmacology

Volumn 21, Issue 3, 2007, Pages 321-337

  Boeijinga, Peter H ^a   Soufflet, L ^a   Santoro, F ^a   Luthringer, R ^a  

^a FORENAP   (France)

Author keywords

Human auditory responses; Ketamine; Magnetoencephalography; NMDA receptors; Schizophrenia; Sensory gating

Indexed keywords

KETAMINE; PLACEBO;

ADULT; AMPLITUDE MODULATOR; ARTICLE; AUDITORY RESPONSE; AUDITORY STIMULATION; BRIEF PSYCHIATRIC RATING SCALE; CENTRAL NERVOUS SYSTEM; CHANNEL GATING; CONTROLLED STUDY; DIPOLE; ELECTRIC POTENTIAL; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EVOKED SOMATOSENSORY RESPONSE; GATED IMAGING; HUMAN; HUMAN EXPERIMENT; MAGNETOENCEPHALOGRAPHY; MALE; NEGATIVE SYNDROME; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOSIS; SCALP; STIMULUS RESPONSE;

ACOUSTIC STIMULATION; ADULT; AUDITORY PERCEPTION; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; MAGNETOENCEPHALOGRAPHY; MALE; MIDDLE AGED; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 34250658827     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107077768     Document Type: Article

References (107)

1. Abduljawad K.A., Langley R.W., Bradshaw C.M., Szabadi E. (1999) Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man. J Psychopharmacol 13: 3 - 9
2. Abel K.M., Allin M.P., Hemsley D.R., Geyer M.A. (2003) Low dose ketamine increases prepulse inhibition in healthy men. Neuropharmacol 44: 729 - 737
3. Adler L.E., Pachtman E., Franks R.D., Pecevich M., Waldo M.C., Freedman R. (1982) Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17: 639 - 654
4. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., Potkin S.G., Sandman C.A., Bunney W.E. Jr, Jones E.G. (1996) Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 16: 19 - 30
5. American Psychiatric Association (APA). (1994) Diagnostic and Statistical Manual of Mental Disorders, 4 th ed: DSM-IV
6. Andreasen N.C. (1982) Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 39: 784 - 788
7. Andreasen N.C. (1995) Symptoms, signs and diagnosis of schizophrenia. Lancet 346: 477 - 481
8. Angrist B., Sathananthan G., Wilk S., Gershon S. (1974) Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 11: 13 - 23
9. Anis N.A., Berry S.C., Burton N.R., Lodge D. (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 79: 565 - 575
10. Bender S., Schall U., Wolstein J., Grzella I., Zerbin D., Oades R.D. (1999) A topographic event-related potential follow-up study on 'prepulse inhibition ' in first and second episode patients with schizophrenia. Psychiatry Res 90: 41 - 53
11. Blumenfeld L.D., Clementz B.A. (2001) Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG. Clin Neurophysiol 112: 1650 - 1659
12. Bolton S. (1990) Pharmaceutical Statistics: Practical and Clinical Applications, 2 nd edition, Chapter 7. Marcel Dekker, New York, Basel, pp. 210 - 257
13. Boutros N.N., Belger A., Campbell D., D'Souza C., Krystal J. (1999) Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Res 88: 119 - 130
14. Boutros N.N., Korzyukov O., Jansen B., Feingold A., Bell M. (2004) Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res 126: 203 - 215
15. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiol 15: 339 - 343
16. Braff D.L., Geyer M.A. (1990) Sensorimotor gating and schizophrenia. Human and animal studies. Archives of General Psychiatry 47: 181 - 188
17. Braff D.L., Geyer M.A., Swerdlow N.R. (2001) Human studies of prepulse inhibition of startle: Normal participants, patient groups, and pharmacological studies. Psychopharmacology 156: 234 - 258
18. Buchanan R.W., Carpenter W.T. (1994) Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia 182: 193 - 204
19. Cadenhead K.S., Light G.A., Geyer M.A., Braff D.L. (2000 a) Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry 157: 55 - 59
20. Cadenhead K.S., Swerdlow N.R., Schafer K.M., Diaz M., Braff D.L. (2000 b) Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry 157: 1660 - 1668
21. Canal N.M., Gourevitch R., Sandner G. (2001) Non-monotonic dependency of PPI on temporal parameters: differential alteration by ketamine and MK-801 as opposed to apomorphine and DOI. Psychopharmacol 156: 169 - 176
22. Cardenas V.A., Gill P., Fein G. (1997) Human P50 suppression is not affected by variations in wakeful alertness. Biol Psychiatry 41: 891 - 901
23. Carlsson A., Hansson L.O., Waters N., Carlsson M.L. (1999) A glutamatergic deficiency model of schizophrenia. Br J Psychiatry Suppl 37: 2 - 6
24. Carpenter W.T. Jr (1999) The schizophrenia ketamine challenge study debate. Biol Psychiatry 46: 1081 - 1091
25. Clementz B.A., Geyer M.A., Braff D.L. (1997) P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biol Psychiatry 41: 1035 - 1044
26. Coppola R. (1979) Isolating low frequency activity in EEG spectrum analysis. Electroenceph Clin Neurophysiol 46: 224 - 226
27. Coyle J.T. (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 3: 241 - 253
28. Dahmen J.C., Corr P.J. (2004) Prepulse-elicited startle in prepulse inhibition. Biol Psychiatry 55: 98 - 101
29. de Bruin N M W J, Ellenbroek B.A., Cools A.R., Coenen A M L, van Luijtelaar E L J M (1999) Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats. Psychopharmacology 142: 9 - 17
30. Domino E.F., Luby E.D. (1981) Abnormal Mental States Induced by Phencyclidine as a Model of Schizophrenia. In Domino E F ed. PCP (Phencyclidine). History and Current Perspectives. NPP Books, Ann Arbor, MI
31. Duncan E.J., Madonick S.H., Parwani A., Angrist B., Rajan R., Chakravorty S., Efferen T.R., Szilagyi S., Stephanides M., Chappell P.B., Gonzenbach S., Ko G.N., Rotrosen J.P. (2001) Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology 25: 72 - 83
32. Erwin R.J., Mawhinney-Hee M., Gur R.C., Gur R.E. (1991) Midlatency auditory evoked responses in schizophrenia. Biol Psychiatry 30: 430 - 442
33. Freedman R., Adler L.E., Waldo M.C., Pachtman E., Franks R.D. (1983) Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol Psychiatry 18: 537 - 551
34. Gallinat J., Mulert C., Bajbouj M., Herrmann W.M., Schunter J., Senkowski D., Mouktieva R., Kronfeldt D., Winterer G. (2002) Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. NeuroImage 17: 110 - 127
35. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156: 117 - 154
36. Geyer M.A. (2006) Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia? Dialogues Clin Neurosci 8: 9 - 16
37. Graham F.K. (1975) The more or less startling effects of weak prestimulation. Psychophysiol 12: 238 - 248
38. Graham F.K., Putnam L.E., Leavitt L.A. (1975) Lead-stimulation effects of human cardiac orienting and blink reflexes. J Exp Psychol Hum Percept Perform 104: 175 - 182
39. Graham S.J., Scaife J.C., Balboa Verduzco A.M., Langley R.W., Bradshaw C.M., Szabadi E. (2004) Effects of quetiapine and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol 18: 173 - 180
40. Grunwald T., Boutros N.N., Pezer N., von Oertzen J., Fernandez G., Schaller C., Elger C.E. (2003) Neuronal substrates of sensory gating within the human brain. Biol Psychiatry 53: 511 - 519
41. Gutschalk A., Micheyl C., Melcher J.R., Rupp A., Scherg M., Oxenham A.J. (2005) Neuromagnetic correlates of streaming in human auditory cortex. J Neurosci 25: 5382 - 5388
42. Hamm A.O., Weike A.I., Schupp H.T. (2001) The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues. Psychopharmacology (Berl) 156: 259 - 265
43. Hanlon F.M., Miller G.A., Thoma R.J., Irwin J., Jones A., Moses S.N., Huang M., Weisend M.P., Paulson K.M., Edgar J.C., Adler L.E., Canive J.M. (2005) Distinct M50 and M100 auditory gating deficits in schizophrenia. Psychophysiol 42: 417 - 427
44. Hari R., Aittoniemi K., Jarvinen M.L., Katila T., Varpula T. (1980) Auditory evoked transient and sustained magnetic fields of the human brain. Localization of neural generators. Exp Brain Res 40: 237 - 240
45. Hetrick W.P., Sandman C.A., Bunney W.E. Jr, Jin Y., Potkin S.G., White M.H. (1996) Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry 39: 51 - 58
46. Hsieh M.H., Liu K., Liu S-K., Chiu M-J., Hwu H-G., Chen A C N (2004) Memory impairment and auditory evoked potential gating deficit in schizophrenia. Psychiatry Res NeuroImaging 130: 161 - 169
47. Huotilainen M., Winkler I., Alho K., Escera C., Virtanen J., Ilmoniemi R.J., J̈̈skel̈inen I.P., Pekkonen E., N̈̈ẗnen R. (1998) Combined mapping of human auditory EEG and MEG responses. Electroenceph Clin Neurophysiol 108: 370 - 379
48. Javitt D.C., Zukin S.R. (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301 - 1308
49. Javitt D.C., Steinschneider M., Schroeder C.E., Arezzo J.C. (1996) Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA 93: 11962 - 11967
50. Javitt D.C., Jayachandra M., Lindsley R.W., Specht C.M., Schroeder C.E. (2000 a) Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP). Clin Neurophysiol 111: 833 - 836
51. Javitt D.C., Shelley A.M., Silipo G., Lieberman J.A. (2000 b) Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Arch Gen Psychiatry 57: 1131 - 1137
52. Kreitschmann-Andermahr I., Rosburg T., Demme U., Gaser E., Nowak H., Sauer H. (2001) Effect of ketamine on the neuromagnetic mismatch field in healthy humans. Brain Res Cogn Brain Res 12: 109 - 116
53. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B. Jr, Charney D.S. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199 - 214
54. Krystal J.H., Belger A., D'Souza D.C., Anand A., Charney D.S., Aghajanian G.K. (1999) Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists. Neuropsychopaharmacol 21: 143 - 157 Krystal J.H., Perry E.B. Jr, Gueorguieva R., Belger A., Madonick S.H., Abi-Dargham A., Cooper T.B., Macdougall L., Abi-Saab W., D'Souza D.C. (2005) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62: 985 - 994
55. Lahti A.C., Weiler M.A., Tamara Michaelidis B.A., Parwani A., Tamminga C.A. (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25: 455 - 467
56. Lecrubier Y. (1997) [Schizophrenia, from classification to dimensions: value of longitudinal studies]. Encephale 23 (Suppl 2). 39 - 43
57. Lieberman J.A., Kinon B.J., Loebel A.D. (1990) Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 16: 97 - 110
58. Light G.A., Braff D.L. (1999) Human and animal studies of schizophrenia-related gating deficits. Curr Psychiatry Rep 1: 31 - 40
59. Light G.A., Braff D.L. (2001) Measuring P50 suppression and prepulse inhibition in a single recording session. Am J Psychiatry 158: 2066 - 2068
60. Luby E.D., Cohen B.D., Rosenbaum G., Gottlieb J.S., Kelley R. (1959) Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry 81: 363 - 369
61. Ludewig K., Geyer M.A., Vollenweider F.X. (2003) Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biol Psychiatry 54: 121 - 128
62. Mansbach R.S., Geyer M.A. (1991) Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine. Psychopharmacology Berl 105: 162 - 168
63. Meincke U., Light G.A., Geyer M.A., Braff D.L., Gouzoulis-Mayfrank E. (2004) Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia. Psychiatry Res 126: 51 - 61
64. Millan M.J. (2005) N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 179: 30 - 53
65. N̈̈ẗnen R., Picton T. (1987) The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure. Psychophysiol 24: 375 - 425
66. Nagamoto H.T., Adler L.E., Waldo M.C., Freedman R. (1989) Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol Psychiatry 25: 549 - 561
67. Newcomer J.W., Farber N.B., Jevtovic-Todorovic V., Selke G., Melson A.K., Hershey T., Craft S., Olney J.W. (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacol 20: 106 - 118
68. Nishitani N., Nagamine T., Fujiwara N., Yazawa S., Shibasaki H. (1998) Cortical-hippocampal auditory processing identified by magnetoencephalography. J Cogn Neurosci 10: 231 - 247
69. Ohtomo S. (1998) Hemispheric asymmetry of the auditory evoked N100m response in relation to the crossing point between the central sulcus and Sylvian fissure. Electroencephalogr Clin Neurophysiol 108: 219 - 225
70. Onitsuka T., Ninomiya H., Sato E., Yamamoto T., Tashiro N. (2000) The effect of interstimulus intervals and between-block rests on the auditory evoked potential and magnetic field: is the auditory P50 in humans an overlapping potential? Clin Neurophysiol 111: 237 - 245
71. Olney J.W., Farber N.B. (1995) NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13: 335 - 345
72. Oranje B., Van Berckel B.N., Kemner C., van Ree J.M., Kahn R.S., Verbaten M.N. (1999) P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study. Biol Psychiatry 45: 883 - 890
73. Oranje B., van Berckel B.N., Kemner C., van Ree J.M., Kahn R.S., Verbaten M.N. (2000) The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology 22: 293 - 302
74. Oranje B., Geyer M.A., Bocker K.B., Leon Kenemans J, Verbaten M.N. (2006) Prepulse inhibition and P50 suppression: Commonalities and dissociations. Psychiatry Res 143: 147 - 158
75. Overall J.E., Gorham D.R. (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10: 799 - 812
76. Pantev C., Bertrand O., Eulitz C., Verkindt C., Hampson S., Schuierer G., Elbert T. (1995) Specific tonotopic organizations of different areas of the human auditory cortex revealed by simultaneous magnetic and electric recordings. Electroencephalogr Clin Neurophysiol 94: 26 - 40
77. Parwani A., Duncan E.J., Bartlett E., Madonick S.H., Efferen T.R., Rajan R., Sanfilipo M., Chappell P.B., Chakravorty S., Gonzenbach S., Ko G.N., Rotrosen J.P. (2000) Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 47: 662 - 669
78. Perlstein W.M., Fiorito E., Simons R.F., Graham F.K. (1993) Lead stimulation effects on reflex blink, exogenous brain potentials, and loudness judgments. Psychophysiol 30: 347 - 358
79. Perry W., Feifel D., Minassian A., Bhattacharjie I., Braff D.L. (2002) Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission. Am J Psychiatry 159: 1375 - 1381
80. Polich J., Kok A. (1995) Cognitive and biological determinants of P300: an integrative review. Biol Psychol 41: 103 - 146
81. Postma P., Kumari V., Hines M., Gray J.A. (2001) The relationship between prepulse detection and prepulse inhibition of the acoustic startle reflex. Psychophysiol 38: 377 - 382
82. Reite M., Teale P., Sheeder J., Rojas D., Simon J. (1996) Neuropsychiatric applications of MEG. Electroencephalogr Clin Neurophysiol Suppl 47: 363 - 382
83. Rosburg T., Kreitschmann-Andermahr I., Nowak H., Sauer H. (2000) Habituation of the auditory evoked field component N100m in male patients with schizophrenia. J Psychiatry Res 34: 245 - 254
84. Schall U., Schon A., Zerbin D., Eggers C., Oades R.D. (1996) Event-related potentials during an auditory discrimination with prepulse inhibition in patients with schizophrenia, obsessive-compulsive disorder and healthy subjects. Int J Neurosci 84: 15 - 33
85. Schall U., Ward P.B. (1996) ' Prepulse inhibition' facilitates a liberal response bias in an auditory discrimination task. Neuroreport 7: 652 - 656
86. Schall U., Schon A., Zerbin D., Bender S., Eggers C., Oades R.D. (1997) A left temporal lobe impairment of auditory information processing in schizophrenia: an event-related potential study. Neurosci Lett 229: 25 - 28
87. Scherg M., Von Cramon D (1986) Evoked dipole source potentials of the human auditory cortex. Electroencephalogr Clin Neurophysiol 65: 344 - 360
88. Seeman P. (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1: 133 - 152
89. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl 20). 22 - 33
90. Smith D.A., Boutros N.N., Schwarzkopf S.B. (1994) Reliability of P50 auditory event-related potential indices of sensory gating. Psychophysiol 31: 495 - 502
91. Siedenberg R., Goodin D.S., Aminoff M.J., Rowley H.A., Roberts T.P. (1996) Comparison of late components in simultaneously recorded event-related electrical potentials and event-related magnetic fields. Electroencephalogr Clin Neurophysiol 99: 191 - 197
92. Steinpreis R.E. (1996) The behavioural and neurochemical effects of phencyclidine in humans and animals: some implications for modelling psychosis. Behav Brain Res 74: 45 - 55
93. Strous R.D., Javitt D.C. (1996) The N-methyl-D-aspartate receptor and schizophrenia. Isr J Med Sci 32: 275 - 281
94. Swerdlow N.R., Caine S.B., Braff D.L., Geyer M.A. (1992) The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J Psychopharmacol 6: 176 - 190
95. Swerdlow N.R., Braff D.L., Geyer M.A. (2000) Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11: 185 - 204
96. Swerdlow N.R., Talledo J., Shoemaker J.M., Codon K., Goins J., Auerbach P.P. (2004) Weak prepulses inhibit but do not elicit startle in rats and humans. Biol Psychiatry 55: 1195 - 1198
97. Tiihonen J., Katila H., Pekkonen E., Jaaskelainen I.P., Huotilainen M., Aronen H.J., Ilmoniemi R.J., Rasanen P., Virtanen J., Salli E., Karhu J. (1998) Reversal of cerebral asymmetry in schizophrenia measured with magnetoencephalography. Schizophr Res 30: 209 - 219
98. Toru M. (1994) Excitatory amino acids: implications for psychiatric disorders research. Life Sci 55: 1683 - 1699
99. Ujike H. (2002) Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 4: 177 - 184
100. Umbricht D., Koller R., Vollenweider F.X., Schmid L. (2002) Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 51: 400 - 406
101. Van Berckel B N M, Oranje, van B, Ree, van J M, Verbaten M N, van R J, Kahn R.S. (1998) The effects of low dose ketamine in sensory gating, neuroendicrine secretion and behavior in healthy human subjects. Psychopharmacol 137: 271 - 281
102. Virtanen J., Ahveninen J., Ilmoniemi R.J., Naatanen R., Pekkonen E. (1998) Replicability of MEG and EEG measures of the auditory N1/N1m-response. Electroencephalogr Clin Neurophysiol 108: 291 - 298
103. Vollenweider F.X., Umbricht D., Geyer M.A., Hell D. (2000) Effects of NMDA antagonists and 5-HT2a antagonists on prepulse inhibition in human volunteers. Psychopharmacology 41: 147
104. Wan F.J., Geyer M.A., Swerdlow N.R. (1995) Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology (Berl) 120: 433 - 441
105. Yee B.K., Russig H., Feldon J. (2004 a) Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity. Neuropsychopharmacol 29: 240 - 248
106. Yee B.K., Russig H., Feldon J. (2004 b) The effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice. Neuropsychopharmacol 29: 1865 - 1877
107. Young K.A., Smith M., Rawls T., Elliott D.B., Russell I.S., Hicks P.B. (2001) N100 evoked potential latency variation and startle in schizophrenia. Neuroreport 12: 767 - 773